[HTML][HTML] Brain-derived neurotrophic factor and inflammation in depression: Pathogenic partners in crime?

GA Porter, JC O'Connor - World journal of psychiatry, 2022 - ncbi.nlm.nih.gov
Major depressive disorder is a debilitating disorder affecting millions of people each year.
Brain-derived neurotrophic factor (BDNF) and inflammation are two prominent biologic risk …

Blood brain-derived neurotrophic factor (BDNF) and major depression: do we have a translational perspective?

B Arosio, FR Guerini, RCO Voshaar… - Frontiers in behavioral …, 2021 - frontiersin.org
Major depressive disorder (MDD) affects millions of people worldwide and is a leading
cause of disability. Several theories have been proposed to explain its pathological …

[HTML][HTML] Peripheral blood inflammatory markers in depression: Response to electroconvulsive therapy and relationship with cognitive performance

KM Ryan, DM McLoughlin - Psychiatry Research, 2022 - Elsevier
The inflammatory response may play a role in depression and the response to
antidepressants. Electroconvulsive therapy (ECT), the most acutely powerful antidepressant …

BDNF blood levels after electroconvulsive therapy in patients with mood disorders: An updated systematic review and meta-analysis

R Pelosof, LA Santos, LC Farhat… - The World Journal of …, 2023 - Taylor & Francis
Abstract Objectives Studies have suggested Brain-Derived Neurotrophic Factors (BDNF)
increase after electroconvulsive therapy (ECT) although they were methodologically limited …

Acute and subsequent continuation electroconvulsive therapy elevates serum BDNF levels in patients with major depression

T Vanicek, GS Kranz, B Vyssoki, G Fugger… - Brain stimulation, 2019 - Elsevier
Introduction The induction of brain-derived neurotrophic factor (BDNF) release and
subsequent restoration of neuroplastic homeostasis may underlie the effects of …

Association of serum BDNF level and Val66Met polymorphism with response to treatment in patients of major depressive disease: A step towards personalized …

P Pathak, A Mehra, S Ram, A Pal, S Grover - Behavioural Brain Research, 2022 - Elsevier
Background Major depressive disorder (MDD) is one of the most common psychiatric
disorders and only less than 50% of MDD patients achieve remission after the first …

The association of brain-derived neurotrophic factor with the diagnosis and treatment response in depression

M Nikolac Perkovic, M Gredicak, M Sagud… - Expert review of …, 2023 - Taylor & Francis
Introduction Recent evidence from the studies evaluating the association between brain-
derived neurotrophic factor (BDNF) concentration/levels, BDNF Val66Met (rs6265) …

Nonremission after electroconvulsive therapy in individuals with major depression: role of borderline personality disorder

M Hein, A Mungo, G Loas - The Journal of ECT, 2022 - journals.lww.com
Objectives The aim of the present study was to investigate the risk of nonremission following
electroconvulsive therapy (ECT), as associated with borderline personality disorder, in …

BDNF-related mutations in major depressive disorder: a systematic review

J Hartig, B Nemeş - Acta Neuropsychiatrica, 2023 - cambridge.org
Objective: A better understanding of the genetic, molecular and cellular mechanisms of brain-
derived neurotrophic factor (BDNF) and its association with neuroplasticity could play a …

Whole blood mitochondrial DNA copy number in depression and response to electroconvulsive therapy

KM Ryan, E Doody, DM McLoughlin - Progress in Neuro …, 2023 - Elsevier
Mitochondrial dysfunction may play a role in various psychiatric conditions. Mitochondrial
DNA copy number (mtDNAcn), the ratio of mitochondrial DNA to nuclear DNA, represents an …